Hypervision
AI NativeMaking surgeries more precise, safer and faster. Powering the future of surgery using hyperspectral intelligence.
Making surgeries more precise, safer and faster. Powering the future of surgery using hyperspectral intelligence.
Published Oct 13, 2026
| Starting Price | Quote-based (not public) | Quote-based (not public) | Typically bundled / ecosystem-based; quote-based |
| Primary Use Case | Contrast-agent-free quantitative oxygenation/perfusion mapping; hospitals seeking advanced spectral imaging | Fluorescence-guided perfusion/lymphatic mapping with on-label agent positioning | Robotic surgery workflows where fluorescence imaging is integrated |
| Key Strength | Injection-free approach using visible/near-visible spectral imaging; quantitative maps; FDA-cleared system | Established market presence in fluorescence imaging; on-label mapping claims (agent + system pairing) | Tight integration into da Vinci workflow; widely adopted robotic platform |
| Key Weakness | Limited public user-review footprint; integration and workflow adoption risk; security posture not publicly documented | Requires injected fluorescent agents; fluorescence interpretation can be subjective; agent logistics | Locked to Intuitive ecosystem; fluorescence requires dye; may not be ideal outside robotic cases |
—
Where Hypervision is positioned to differ:
Where alternatives may be stronger:
Buyer diligence point: Determine whether Hypervision is best viewed as a standalone cart/system purchase, or a module that integrates into existing laparoscopic/open visualization workflows.